CD8A and neoplasm: Ford et al. [117] found that CAF induce immunotherapies resistance via specifically excluding CD8 + T-cells from the tumor mass, and they found that by the inhibition of NOX4, CAF can be precisely targeted to decrease and revert CAF differentiation, inducing CD8+ T-cell infiltration, and restore the sensitivity of CAF-rich tumor to immunotherapy.